Merger with Kintara Therapeutics - Additional Information (Details)		12 Months Ended
	Oct. 18, 2024 shares	Dec. 31, 2024 USD ($) shares	Dec. 31, 2023 shares
Business Acquisition [Line Items]
Common stock, shares issued		42,323,759	12,167,679
Common stock, shares outstanding	42,032,165	42,323,759	12,167,679
Expected term		6 years	4 years 10 months 24 days
Dividend yield		0.00%	0.00%
Issuance of shares | $		$ (1,346,912)
Kintara Therapeutics Inc [Member]
Business Acquisition [Line Items]
Common stock, shares issued	40,441,605	40,441,605
Common stock exchange ratio	0.1789	0.1789